首页 › 基金 › Capricorn Fund Managers Ltd › MIRM

Capricorn Fund Managers Ltd 对 MIRM 的持仓历史

MIRUM PHARMACEUTICALS INC · 医疗保健

Capricorn Fund Managers Ltd 在 Q2 2026 的 13F 申报中披露持有 MIRM(MIRUM PHARMACEUTICALS INC)101,240 股,市值约 US$11.9M,约占其申报组合的 0.94%,在其申报持仓中市值排名第 36 位。 Capricorn Fund Managers Ltd 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)101.24K 股
申报持仓市值$11.85M
组合权重0.94%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Capricorn Fund Managers Ltd 对 MIRM 的持仓演变

Capricorn Fund Managers Ltd 于 Q2 2026 首次披露 MIRM 持仓:101,240 股(约 US$11.9M)。

逐季持仓明细

季度股数金额变化
Q2 2026 101.24K $11.85M 新进

关于 MIRM 与 13F 数据

MIRM(MIRUM PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 62 只申报持有 MIRM,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MIRM 的基金

查看 MIRM 的全部基金持有人 →

常见问题

How long has Capricorn Fund Managers Ltd held MIRM?

Capricorn Fund Managers Ltd has disclosed MIRM holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Capricorn Fund Managers Ltd's current position in MIRM?

As of Q2 2026, Capricorn Fund Managers Ltd holds 101.24K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $11.85M, representing 0.94% of its reported portfolio and ranking #36.

Has Capricorn Fund Managers Ltd been buying or selling MIRM?

In the latest 13F filing (Q2 2026), Capricorn Fund Managers Ltd newly opened its position in MIRM.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.